Obsessive Compulsive Disorder Funding This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Early Stage Testing of Pharmacologic or Device -based Interventions for the Treatment of Mental Health Disorders (R33- Clinical Trial Required)
Funding Opportunity RFA-MH-18-703 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the early stage testing of pharmacologic interventions with novel mechanisms of action or device-based interventions, for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g., schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder). Early intervention studies are also encouraged where symptoms of a disorder have been identified in subjects (a prodromal phase), prior to full diagnostic crit...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2017 Category: Research Source Type: funding

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33-Clinical Trial Required)
Funding Opportunity RFA-MH-18-702 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the early stage testing of pharmacologic interventions with novel mechanisms of action, or device-based interventions, for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g., schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder). Early intervention studies are also encouraged where symptoms of a disorder have been identified in subjects (a prodromal phase), prior to full diagnostic cri...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 14, 2017 Category: Research Source Type: funding

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
Funding Opportunity ID: 290644 Opportunity Number: RFA-MH-17-600 Opportunity Title: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.242Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments...
Source: Grants.gov - December 13, 2016 Category: Research Tags: Health Source Type: funding

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33)
Funding Opportunity ID: 290627 Opportunity Number: RFA-MH-17-602 Opportunity Title: Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.242Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Fe...
Source: Grants.gov - December 13, 2016 Category: Research Tags: Health Source Type: funding

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33)
Funding Opportunity RFA-MH-17-602 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the early stage testing of pharmacologic interventions with novel mechanisms of action or device-based interventions, for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g. schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder, etc.). Early intervention studies are also encouraged where symptoms of a disorder have been identified in subjects (a prodromal phase), prior to full diagnostic...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 13, 2016 Category: Research Source Type: funding

Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
Funding Opportunity RFA-MH-17-600 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the early stage testing of pharmacologic interventions with novel mechanisms of action, or device-based interventions, for the treatment of symptoms or domains of altered functions in individuals with mental illness (e.g. schizophrenia, depression, autism, obsessive compulsive disorder, anxiety, bipolar disorder, etc.). Early intervention studies are also encouraged where symptoms of a disorder have been identified in subjects (a prodromal phase), prior to full diagnosti...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 13, 2016 Category: Research Source Type: funding

International OCD Foundation Research Grant Program
IOCDF Research Grants Submissions will be accepted January 2, 2014 to February 28, 5pm EST, 2014. The mission of the International OCD Foundation is to help individuals with obsessive compulsive disorder (OCD) and related disorders to live full and productive lives. Our aim is to increase access to effective treatment, end the stigma associated with mental health issues, and foster a community for those affected by OCD and the professionals who treat them. About Our Research Grants The IOCDF awards grants to investigators whose research focuses on the nature, causes and treatment of OCD and related disorde...
Source: ScanGrants feed - December 10, 2013 Category: Research Authors: International OCD Foundation Source Type: funding